High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.0M
$1,962,781
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KNSA
M
Kiniksa Pharmaceuticals International, plc
Megna Michael R
• Officer • CHIEF ACCOUNTING OFFICER
Other
2025-10-20
$456,999x5
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Officer • CHIEF ACCOUNTING OFFICER
Other
|
2025-10-20 | $456,999x5 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Megna Michael R
• Officer • CHIEF ACCOUNTING OFFICER
10b5-1 SellΔOwn -32.9%
2025-10-20
$1,962,781Largex2
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Officer • CHIEF ACCOUNTING OFFICER
10b5-1 SellΔOwn -32.9%
|
2025-10-20 | $1,962,781Largex2 | S | Form 4 |